ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
Schulz-Schupke, S., Byrne, R. A.
, ten Berg, J. M., Neumann, F.-J., Han, Y., Adriaenssens, T., Tolg, R., Seyfarth, M., Maeng, M., Zrenner, B., Jacobshagen, C., Mudra, H., von Hodenberg, E., Wohrle, J., Angiolillo, D. J., von Merzljak, B., Rifatov, N., Kufner, S.
, Morath, T., Feuchtenberger, A., Ibrahim, T., Janssen, P. W. A., Valina, C., Li, Y., Desmet, W., Abdel-Wahab, M., Tiroch, K., Hengstenberg, C., Bernlochner, I., Fischer, M., Schunkert, H., Laugwitz, K.-L., Schomig, A., Mehilli, J. and Kastrati, A.
(2015)
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
European Heart Journal 36 (20), pp. 1252-1263.
Date of publication of this fulltext: 19 Dec 2024 07:34
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Heart Journal | ||||
| Publisher: | OXFORD UNIV PRESS | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 36 | ||||
| Number of Issue or Book Chapter: | 20 | ||||
| Page Range: | pp. 1252-1263 | ||||
| Date | 2015 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin II | ||||
| Identification Number |
| ||||
| Keywords | DUAL-ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTIONS; CLINICAL-TRIALS; IMPLANTATION; EFFICACY; THROMBOSIS; DURATION; DISCONTINUATION; GUIDELINES; RISK; Clopidogrel; Double-blind; Dual antiplatelet therapy; Drug-eluting stent; Randomized trial; Stent thrombosis | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 60418 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric